At your organization, do you use ceftriaxone in neonates? If so, can you please share your criteria for use?
Additional questions:
- Do you have any electronic (EMR) safeguards in place to alert if a patient has received IV calcium containing products 48 hours prior and post 48 hours of ceftriaxone?
 a) If yes, Does the alert capture one-time doses or doses administered in the ED or OR? Can you please share how the alert is built?
 b) If no, Are there non-EMR safeguards in place?
      Mon, 10/09/2023 - 06:45
                
    
    
        
    #1
  
          Ceftriaxone use in neonates        
      
      
